珈凯生物 (874687.OC)

+ 收藏

利润表(珈凯生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2025年中报2025年一季报2024年年报2024年中报2024年一季报2023年年报
上市前/上市后 上市后上市后上市前上市前上市前上市前
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 会员可见会员可见会员可见会员可见50,938,266.05217,502,020.54
 营业收入(元) 会员可见会员可见会员可见会员可见50,938,266.05217,502,020.54
二、营业总成本(元) 会员可见会员可见会员可见会员可见40,817,849.45163,768,479.88
 营业成本(元) 会员可见会员可见会员可见会员可见17,974,231.8578,967,167.30
 研发费用(元) 会员可见会员可见会员可见会员可见4,851,211.2318,380,492.80
 营业税金及附加(元) 会员可见会员可见会员可见会员可见762,094.672,255,834.41
 销售费用(元) 会员可见会员可见会员可见会员可见10,443,820.1236,628,761.47
 管理费用(元) 会员可见会员可见会员可见会员可见6,429,482.2225,219,598.23
 财务费用(元) 会员可见会员可见会员可见会员可见357,009.362,316,625.67
  其中:利息费用(元) 会员可见会员可见会员可见会员可见445,269.052,699,595.67
三、其他经营收益
 加:公允价值变动收益(元) -会员可见----
 加:投资收益(元) 会员可见会员可见会员可见会员可见-161,315.07
 资产处置收益(元) --会员可见会员可见-454,317.69
 资产减值损失(元) 会员可见会员可见会员可见会员可见-321,158.35-593,488.13
 信用减值损失(元) 会员可见会员可见会员可见会员可见-300,253.55-61,756.70
 其他收益(元) 会员可见会员可见会员可见会员可见1,424,762.751,012,584.50
四、营业利润(元) 会员可见会员可见会员可见会员可见10,923,767.4554,706,513.09
 加:营业外收入(元) 会员可见会员可见会员可见会员可见-7,812.99
  其中:非流动资产处置利得(元) -----152.53
 减:营业外支出(元) 会员可见会员可见会员可见会员可见14,711.7231,142.98
五、利润总额(元) 会员可见会员可见会员可见会员可见10,909,055.7354,683,183.10
 减:所得税费用(元) 会员可见会员可见会员可见会员可见1,115,847.267,164,020.56
六、净利润(元) 会员可见会员可见会员可见会员可见9,793,208.4747,519,162.54
(一)按经营持续性分类
  持续经营净利润(元) 会员可见会员可见会员可见会员可见9,793,208.4747,519,162.54
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 会员可见会员可见会员可见会员可见9,793,208.4747,519,162.54
 扣除非经常性损益后的净利润(元) 会员可见会员可见会员可见-9,447,900.0046,115,873.35
七、每股收益
 一、基本每股收益(元) 会员可见会员可见会员可见会员可见0.241.19
 二、稀释每股收益(元) 会员可见会员可见会员可见会员可见0.241.19
九、综合收益总额(元) 会员可见会员可见会员可见会员可见9,793,208.4747,519,162.54
 归属于母公司所有者的综合收益总额(元) 会员可见会员可见会员可见会员可见9,793,208.4747,519,162.54
公告日期 2025-08-262025-06-112025-04-242025-08-262024-09-252024-09-25
审计意见(境内) --标准无保留意见-标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院